Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 7/20 | 0.65 |
| ▸ | PPARG | P37231 | 6/20 | 0.65 |
| ▸ | ACE | P12821 | 1/20 | 0.62 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.62 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.62 |
| ▸ | CTSS | P25774 | 6/20 | 0.56 |
| ▸ | CTSK | P43235 | 5/20 | 0.56 |
| ▸ | CTSL | P07711 | 2/20 | 0.55 |
| ▸ | CTSB | P07858 | 1/20 | 0.55 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.53 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.53 |
| ▸ | PPARD | Q03181 | 2/20 | 0.52 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.52 |
| ▸ | ITGAV | P06756 | 1/20 | 0.52 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1309909 | 1.00 | PPARA (0.65) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL181849 | 1.00 | PPARA (0.65) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL3722240 | 0.96 | PPARA (0.61) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL22009950 | 0.96 | PPARA (0.61) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL3722245 | 0.96 | PPARA (0.61) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL2290585 | 0.94 | ITGB3 (0.62) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL2290589 | 0.94 | ITGB3 (0.62) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL2287582 | 0.91 | ITGB3 (0.59) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL2287578 | 0.91 | ITGB3 (0.59) | PPARAPPARGACEITGB3ITGA2B | |
| SCHEMBL7481627 | 0.89 | PPARG (0.59) | PPARAPPARGACEITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104910046-B | Phenylacetylene derivative with double chiral carbon atoms on pendant group and preparation method and application thereof | 哈尔滨工程大学 | 2017-05-24 | — | — | CN | claimed |
| CN-104910039-A | Functional phenylacetylene compound and preparation method thereof | UNIV HARBIN ENG | 2015-09-16 | — | — | CN | claimed |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2012-02-16 | — | — | US | claimed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| EP-4702033-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| US-20260001924-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | NEW YORK UNIVERSITY (US) | 2026-01-01 | — | — | US | disclosed |
| US-12486302-B2 | Somatostatin receptor antagonist compounds and methods of using the same | CDRD VENTURES INC. (CA) | 2025-12-02 | — | — | US | disclosed |
| US-12404265-B2 | Substituted pyridine derivatives as SARM1 inhibitors | NURA BIO, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-12371461-B2 | Nemo coiled coil mimics and methods of using same | NEW YORK UNIVERSITY (US) | 2025-07-29 | — | — | US | disclosed |
| US-12371406-B2 | Dual acting FKBP12 and FKBP52 inhibitors | PLEX PHARMACEUTICALS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4269400-B1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | MOLECURE SA (PL) | 2025-07-09 | — | — | EP | disclosed |
| EP-0215171-A2 | Peptides | THE ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND (US) | 1987-03-25 | — | — | EP | disclosed |
| EP-0081877-B1 | LH-RH ANTAGONISTS | COY, David Howard (US) | 1986-04-30 | — | — | EP | disclosed |
| EP-0041286-B1 | LH-RH ANTAGONISTS | Schally, Andrew Victor (US) | 1984-08-15 | — | — | EP | disclosed |
| US-4431635-A | PEPTIDE ANALOGS OF LUTEINIZING HORMONE RELEASING HORMONE; GLANDULAR DISORDERS; ANTICARCINOGENIC AGENTS | COY DAVID HOWARD | 1984-02-14 | — | — | US | disclosed |
| EP-0081877-A1 | LH-RH antagonists | COY, David Howard (US) | 1983-06-22 | — | — | EP | disclosed |
| US-4317815-A | PEPTIDE ANALOGS OF LUTENIZING HORMONE RELEASING HORMONE | ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND, THE, A CORPORATE ENTITY OF TULANE UNIVERSITY A CORP. OF LA. | 1982-03-02 | — | — | US | disclosed |
| EP-0041286-A1 | LH-RH antagonists | Schally, Andrew Victor (US) | 1981-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404265-B2 | Substituted pyridine derivatives as SARM1 inhibitors | SARM1, SARNP, ADRM1 | PPARA 3678/4885PPARG 2613/4885ACE 1597/4885 |
| US-12371461-B2 | Nemo coiled coil mimics and methods of using same | COIL, CALCOCO2, NCAPH | PPARA 4497/4885PPARG 4002/4885ACE 4652/4885 |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | ACKR3, KIT, C3AR1 | PPARA 3818/4885PPARG 4330/4885ACE 140/4885 |
| US-12486302-B2 | Somatostatin receptor antagonist compounds and methods of using the same | GPR119, SSTR5, SSTR2 | PPARA 798/4885PPARG 729/4885ACE 839/4885 |
| US-20260001924-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | DDX21, PHAX, RBX1 | PPARA 3778/4885PPARG 3003/4885ACE 4863/4885 |
| US-12371406-B2 | Dual acting FKBP12 and FKBP52 inhibitors | FKBP2, FKBP1B, FKBP1A | PPARA 1968/4885PPARG 1485/4885ACE 3863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.